FDA Drug Shortages

$179 / year

Food and Drug Administration (FDA) Drug Shortages includes information about current drugs in shortage and resolved shortages of specific drug products, resource information, and relevant links.

Complexity

Food and Drug Administration (FDA) Drug Shortages includes information about current drugs in shortage and resolved shortages of specific drug products including date first posted, updated date, therapeutic category, estimated shortage duration, resource information and relevant links.

Date Created

2011-02

Last Modified

2020-08-24

Version

2020-08-24

Update Frequency

Monthly

Temporal Coverage

N/A

Spatial Coverage

United States

Source

John Snow Labs; U.S. Food and Drug Administration (FDA);

Source License URL

Source License Requirements

N/A

Source Citation

N/A

Keywords

FDA Drug Shortages, Drug Shortages, FDA Drug Database, FDA Drugs, Current Drug Shortages

Other Titles

Current and Resolved Drug Shortages, Current and Resolved Shortages Listed by Generic Name or Active Ingredient

NameDescriptionTypeConstraints
Generic_Name_or_Active_IngredientProduct Namestringrequired : 1
StatusCurrent_Status_of_the_productstring-
Generic Name or Active IngredientCompany NameCompany Contact InformationPresentationTherapeutic CategoriesStatusDate First PostedLast UpdateAvailability and Estimated Shortage DurationRelated InformationShortage Reason
Abacavir Sulfate and Lamivudine TabletsTeva Pharmaceuticals800-545-8800600 mg and 300 mg (NDC 0093-5382-56)AntiviralTo be Discontinued2020-10-022020-10-02
Abciximab (ReoPro) InjectionJanssen Biotech, Inc.800-586-77362mg/mL (NDC 57894-200-01)CardiovascularTo be Discontinued2018-04-112019-08-15Janssen has made a business decision to discontinue manufacture of the drug product.
Abiraterone Acetate TabletsJanssen Research and Development, LLC800-526-7736250 mg tablets (NDC 57894-155-12)OncologyTo be Discontinued2020-06-052020-06-05
Acarbose (Precose) TabletsBayer888-842-2937Bottles of 100 Tablets 25 mg (NDC 50419-863-51)Endocrinology/MetabolismTo be Discontinued2019-02-012019-02-01Business decision to discontinue marketing in the US.
Acarbose (Precose) TabletsBayer888-842-2937Bottles of 100 Tablets 50 mg (NDC 50419-861-51)Endocrinology/MetabolismTo be Discontinued2019-02-012019-02-01Business decision to discontinue marketing in the US.
Acarbose (Precose) TabletsBayer888-842-2937Bottles of 100 Tablets 100 mg (NDC 50419-862-51)Endocrinology/MetabolismTo be Discontinued2019-02-012019-02-01Business decision to discontinue marketing in the US.
Acarbose (Precose) TabletsBayer888-842-2937Unit Dose 50 mg (NDC 50419-861-48)Endocrinology/MetabolismTo be Discontinued2019-02-012019-02-01Business decision to discontinue marketing in the US.
Acetaminophen/Tramadol Hydrochloride (Ultracet) TabletsJanssen Pharmaceuticals800-526-7736325 mg/1 unit || 37.5 mg/1 unit (NDC 50458-650-60)Analgesia/AddictionTo be Discontinued2020-04-012020-04-01The Company has made a business decision to permanently discontinue Ultracet. Product should be maintained on the formularies until the last batch produced expires (31 Oct 2022), in order to maintain continuity of the reimbursement process.
Acrivastine and Pseudoephedrine Hydrochloride CapsulesEndo Pharmaceuticals, Inc.800-462-3636Semprex-D Capsules, 8 mg/ 60mg , 100 capsules, (NDC 52244-404-10)Pulmonary/AllergyTo be Discontinued2020-06-022020-06-02Endo has made a business decision to permanently discontinue the drug product.
Acyclovir Capsules, USPTeva Pharmaceuticals800-545-8800200 mg, 100 count (NDC 0093-8940-01)AntiviralTo be Discontinued2019-03-212019-03-21Teva made a business decision to discontinue product.